Anesteziologie a intenzivní medicína, 2011 (vol. 22), issue 5

Bezpečná anestezieEditorial

Karel Cvachovec

Anest. intenziv. Med. 2011;22(5):247-248  

Ultrasound guided medial cervical plexus blockadeAnaesthesiology - Original Paper

Nalos Daniel, Humhej Ivan

Anest. intenziv. Med. 2011;22(5):249-252  

Objective:To assess the reliability and safety of ultrasound guided medial cervical plexus blockade. Design:Prospective observational study. Setting:Department of Anesthesiology and Critical Care, Regional Tertiary Hospital. Materials and methods:We studied 50 ASA II-III patients (28 males and 22 females, average age 62 years) undergoing carotid endarterectomy. Medial cervical plexus blockade was performed under ultrasound guidance using "in plane" technique. We injected 20 mL of 0.375% bupivacaine in between the fasciae dividing the sternocleidomastoid and levator scapulae muscles. All patients...

Kardiopulmonálna resuscitáciaBook Reviews

Š. Trenkler

Anest. intenziv. Med. 2011;22(5):252  

The influence of temperature adjustment on thromboelastography results: prospective cohort studyAnaesthesiology - Original Paper

Čundrle Ivan jr., Šrámek Vladimír, Pavlík Martin, Suk Pavel, Radousková Iveta, Zvoníček Václav

Anest. intenziv. Med. 2011;22(5):253-259  

Introduction:Thromboelastography (TEG) and standard coagulation tests are carried out at a laboratory temperature of 37 °C, thus omitting the effects of real blood temperature. The aim of this study was comparing the results of kaolin - heparinase TEG and Rapid TEG during mild therapeutic hypothermia i.e. when the blood was analysed at the actual temperature (isothermia) and at 37°C (normothermia). The second aim was to evaluate the clinical relevance of the results and on their basis to determine the necessity to analyse TEG at the actual temperature. Materials and Methods:Thirty patients following CPR (cardiopulmonary resuscitation),...

Erratum

Anest. intenziv. Med. 2011;22(5):259  

Fibrinolysis in cardiac surgery in the post-aprotinin eraAnaesthesiology - Review articles

Špegár Ján, Pazderková Petra, Vaněk Tomáš

Anest. intenziv. Med. 2011;22(5):260-264  

The use of antifibrinolytics for prevention of massive haemorrhagic events and deterioration during the perioperative course of a patient is a routine practice in many cardiac centres nowadays. Following the withdrawal of the most powerful antifibrinolytic agent aprotinin, attention of the clinical practitioners is focused on tranexamic acid. This article summarizes the beneficial and undesirable effects of tranexamic acid and other antifibrinolytics used in cardiac surgery.

The mechanism of hypotension with intravenous paracetamol in the critically illIntensive Care Medicine - Original Paper

Krajčová Adéla, Matoušek Vojtěch, Duška František

Anest. intenziv. Med. 2011;22(5):266-271  

Objective:To elucidate the mechanism of hypotension caused by intravenous administration of paracetamol (acetaminophen) in the critically ill. Design:Prospective, observational, cross-over study. Setting:Intensive Care Unit, University Hospital. Methods:Mechanically ventilated critically ill patients monitored by PiCCO who were concurrently administered i.v. paracetamol were eligible for the study. We recorded the haemodynamic indices, the core and peripheral temperatures continuously for 3 hours after the administration of paracetamol or a control drug known not to influence the...

Does measuring the intracranial pressure influence survival rates in patients with brain injury?Intensive Care Medicine - Original Paper

Krbila Štefan, Soboňa Viliam, Waczulíková Iveta, Záhorec Roman

Anest. intenziv. Med. 2011;22(5):272-278  

Objective:To compare the outcomes and mortality at 7 and 270 days in brain-injured patients with an inserted ICP sensor to those without an ICP sensor. Type of study:Prospective and comparative clinical study. Materials and methods:The study population, which consisted of 64 patients with brain injury, was divided into a group with continuous ICP monitoring for 7days and a group without ICP monitoring. The follow-up period was between 7 and 270 days. The recorded values and other relevant data were analysed by methods of descriptive and inductive statistics. Results:The differences between the...

Doporučení pro poskytování poanestetické péčeGuidelines

Karel Cvachovec, Vladimír Černý, Ivan Herold, Michal Horáček, Ivan Chytra, Ivana Kupečková, Vladimír Šrámek, Renata Vyhlídalová

Anest. intenziv. Med. 2011;22(5):279-282  

Doporučení pro omezování příjmu tekutin a stravy před anesteziologickou péčíGuidelines

Karel Cvachovec, Ivan Herold, Vladimír Černý, Pavel Ševčík, Michal Horáček

Anest. intenziv. Med. 2011;22(5):282-283  

Doporučený postup pro život ohrožující krvácení (mezioborové konsenzuální stanovisko)Guidelines

Jan Blatný, Karel Cvachovec, Vladimír Černý, Eduard Kasal, Miroslav Penka, Peter Salaj

Anest. intenziv. Med. 2011;22(5):283-285  

18. kongres ČSARIM, Praha 6.-8. 10. Souhrn přednášek a abstrakt - I. částCongresses and Conferences

Anest. intenziv. Med. 2011;22(5):286-293  

EBA recommendations for Safe Medication Practice (June 2011)News from CSARIM

Anest. intenziv. Med. 2011;22(5):294  

WFSA RESEARCH GRANTS 2011News from CSARIM

Anest. intenziv. Med. 2011;22(5):294-295  

Medaile Františka Celestýna OpitzeNews from CSARIM

Anest. intenziv. Med. 2011;22(5):295  

V. česko-slovenský kongres intenzivní medicíny a I. sympozium České resuscitační rady. 11.-13. května 2011, Clarion Congress Hotel PragueNews from CSIM

Anest. intenziv. Med. 2011;22(5):296-297  

Kalendář akcíNews from CSIM

Anest. intenziv. Med. 2011;22(5):297  

Competency based training in intensive care medicine in Europe (první část)News from CSIM

Anest. intenziv. Med. 2011;22(5):298-312  


Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.